Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1978 Nov;31(11):1091–1093. doi: 10.1136/jcp.31.11.1091

Pitfalls in the use of artificial substrates for the diagnosis of Gaucher's disease.

Y Ben-Yoseph, H L Nadler
PMCID: PMC1145491  PMID: 105017

Abstract

A patient with Gaucher's disease is described, in whom the disease could not be diagnosed enzymically in liver and leucocytes using artificial substrate 4-methylumbelliferyl beta-glucoside. Normal activity was found in the liver, and about 60% of control activity was determined in the patient's leucocytes. In contrast, when [14C]-N-stearoyl glucocerebroside was employed as a substrate, activity as low as 5% of control has been found in all the proband's tissues, and carrier levels were determined in the proband's parents and maternal uncle.

Full text

PDF
1091

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BRADY R. O., KANFER J. N., SHAPIRO D. METABOLISM OF GLUCOCEREBROSIDES. II. EVIDENCE OF AN ENZYMATIC DEFICIENCY IN GAUCHER'S DISEASE. Biochem Biophys Res Commun. 1965 Jan 18;18:221–225. doi: 10.1016/0006-291x(65)90743-6. [DOI] [PubMed] [Google Scholar]
  2. Ben-Yoseph Y., Burton B. K., Nadler H. L. Quantitation of the enzymically deficient cross reacting material in GM1 gangliosidoses. Am J Hum Genet. 1977 Nov;29(6):575–580. [PMC free article] [PubMed] [Google Scholar]
  3. Beutler E., Kuhl W. The diagnosis of the adult type of Gaucher's disease and its carrier state by demonstration of deficiency of beta-glucosidase activity in peripheral blood leukocytes. J Lab Clin Med. 1970 Nov;76(5):747–755. [PubMed] [Google Scholar]
  4. Beutler E., Kuhl W., Trinidad F., Teplitz R., Nadler H. Beta-glucosidase activity in fibroblasts from homozygotes and heterozygotes for Gaucher's disease. Am J Hum Genet. 1971 Jan;23(1):62–66. [PMC free article] [PubMed] [Google Scholar]
  5. Broadhead D. M., Butterworth J. The diagnosis of Gaucher's disease in liver using 4-methylumbelliferyl-beta-D-glucopyranoside. Clin Chim Acta. 1977 Feb 15;75(1):155–161. doi: 10.1016/0009-8981(77)90512-5. [DOI] [PubMed] [Google Scholar]
  6. Erickson J. S., Radin N. S. N-hexyl-O-glucosyl sphingosine, an inhibitor of glucosyl ceramide -glucosidase. J Lipid Res. 1973 Mar;14(2):133–137. [PubMed] [Google Scholar]
  7. Kampine J. P., Brady R. O., Kanfer J. N., Feld M., Shapiro D. Diagnosis of gaucher's disease and niemann-pick disease with small samples of venous blood. Science. 1967 Jan 6;155(3758):86–88. doi: 10.1126/science.155.3758.86. [DOI] [PubMed] [Google Scholar]
  8. Owada M., Sakiyama T., Kitagawa T. Neuropathic Gaucher's disease with normal 4-methylumbelliferyl-beta-glucosidase activity in the liver. Pediatr Res. 1977 May;11(5):641–646. doi: 10.1203/00006450-197705000-00004. [DOI] [PubMed] [Google Scholar]
  9. Shapira E., David A., DeGregorio R., Nadler H. L. Separation of beta-galactosidases and beta-glucosidases from human liver. Enzyme. 1976;21(4):332–341. doi: 10.1159/000458876. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES